Beijing Chunlizhengda Medical Instruments (01858) released its performance for the first three quarters, with a net profit attributable to shareholders of 192 million yuan, a year-on-year increase of 213.21%.
Chunli Medical (01858) released its performance for the first three quarters of 2025, with the group achieving a revenue of 756 million yuan,...
Beijing Chunlizhengda Medical Instruments (01858) released its performance for the first three quarters of 2025. The group achieved operating income of 756 million yuan, an increase of 48.75% year-on-year; net profit attributable to shareholders of the listed company was 192 million yuan, an increase of 213.21% year-on-year. Basic earnings per share were 0.5 yuan.
Related Articles

Industrial: Hong Kong stock market sentiment index has reached the bottom area.

"The 'Chinese Choice' for Global SiC Core Customers: Why TIANYU SEMI (02658)?"

Guosen: RWA welcomes the era of strict supervision.
Industrial: Hong Kong stock market sentiment index has reached the bottom area.

"The 'Chinese Choice' for Global SiC Core Customers: Why TIANYU SEMI (02658)?"

Guosen: RWA welcomes the era of strict supervision.

RECOMMEND

Nine Companies With Market Value Over RMB 100 Billion Awaiting, Hong Kong IPO Boom Continues Into 2026
07/02/2026

Hong Kong IPO Cornerstone Investments Surge: HKD 18.52 Billion In First Month, Up More Than 13 Times Year‑On‑Year
07/02/2026

Over 400 Companies Lined Up For Hong Kong IPOs; HKEX Says Market Can Absorb
07/02/2026


